EFung Capital
Venture capitalShenzhen · Seed–Growth
Find your way into EFung Capital
Investment thesis
EFung Capital positions itself as an investment firm dedicated to the biomedical and healthcare sector in China. After repositioning to focus on biomedicine, it raised and deployed its first post-transition fund and increased investment in innovative medical technologies. The firm pursues coordinated domestic and overseas investment, seeking high-quality projects abroad, and has seen numerous portfolio companies list on capital markets. It established a Hainan-based private fund management entity registered with AMAC and, as one of the first signatory institutions, entered a strategic agreement with China's national venture capital guidance fund.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 3 of 20 portfolio companiesBiotech ×3Healthtech ×2Medical Devices ×1
HQs:United States×3
Investments · 20 tracked
founders shown can be your intro path
Centrexion develops therapies for the treatment of pain, focusing on the design and execution of clinical trials for pain drug development.
BiotechHealthtechBaltimore, US
James N. Campbell(President, Chief Scientific Officer)inKerrie L. Brady(Executive Officer)inGregg Beloff(Executive Officer)Jeffrey B. Kindler(Chief Executive Officer)inCharles Oh(Chief Medical Officer)inSmital Shah(Acting CBO)in
Co-investorsCatalio Capital Management, LPNew Enterprise Associates (NEA)Quan Capital6 Dimensions CapitalExome Asset Management
Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients.
BiotechHealthtechMedical DevicesChicago, US
Richard C. Koya(Co-Founder)Kunle Odunsi(Co-Founder)Jay Zhang(CEO)
Co-investorsPanacea VentureVI Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ApexigenElicio亚盛医药亚虹医药前沿生物北芯生命华昊中天和元生物和铂医药微芯生物思路迪医药拨康视云普门科技泰诺麦博盛禾生物真实生物禾元生物荃信生物
Portfolio news
latest coverage across their companiesCentrexion Therapeutics · trysignalbase.com · Mar 25, 2026
Frequently asked questions
- How many investments has EFung Capital made?
- EFung Capital has 20 tracked investments.
- What stage does EFung Capital invest at?
- EFung Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does EFung Capital focus on?
- EFung Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is EFung Capital located?
- EFung Capital is headquartered in Shenzhen, CN.
- Who does EFung Capital co-invest with?
- EFung Capital most often shares deals with Catalio Capital Management, LP, New Enterprise Associates (NEA), Quan Capital, among 4 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.